esketamine has been researched along with Adverse Drug Event in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orsolini, L; Salvi, V; Volpe, U | 1 |
| Kamphuis, J; Kutscher, M; Meij, AV; Schoevers, RA; Smith-Apeldoorn, SY; Veraart, JKE; Vischjager, M | 1 |
| Do, A; Giacobbe, P; Gutierrez, G; Hawken, E; Karthikeyan, G; Lam, RW; Milev, R; Ravindran, N; Rosenblat, J; Schaffer, A; Swainson, J; Vazquez, G | 1 |
| Andriola, I; Barlati, S; Bassetti, R; Chiappini, S; Clerici, M; d'Andrea, G; De Filippis, S; Dell'Osso, B; Di Nicola, M; Martinotti, G; Pettorruso, M; Sensi, S; Vita, A | 1 |
| Chen, H; Ding, X; Fu, Q; Li, P; Liu, Q; Xiang, G; Xu, L | 1 |
| Eppler, F; Häske, D; Heinemann, N; Schempf, B | 1 |
| Bozymski, KM; Crouse, EL; Kirkwood, CK; Nofziger, JL; Ott, CA; Titus-Lay, EN | 1 |
| Barbui, C; Gastaldon, C; Kane, JM; Raschi, E; Schoretsanitis, G | 1 |
| Chen, Q; Wang, X; Xiao, Z; Zhan, Z; Zhang, B | 1 |
| Cao, B; Ceban, F; Chau, EH; Gill, H; Ho, RC; Kratiuk, K; Kumar, A; Lee, JG; Lee, Y; Lin, K; Lipsitz, O; Lui, LMW; Mansur, RB; McIntyre, RS; Nasri, F; Rodrigues, NB; Rosenblat, JD; Subramaniapillai, M; Swainson, J | 1 |
5 review(s) available for esketamine and Adverse Drug Event
| Article | Year |
|---|---|
Craving and addictive potential of esketamine as side effects?
Topics: Adult; Bupropion; Craving; Depressive Disorder, Major; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ketamine | 2022 |
Safety of Ketamine Augmentation to Monoamine Oxidase Inhibitors in Treatment-Resistant Depression: A Systematic Literature Review and Case Series.
Topics: Depression; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Serotonin Syndrome | 2022 |
Analysis of the efficacy of subclinical doses of esketamine in combination with propofol in non-intubated general anesthesia procedures - a systematic review and meta-analysis.
Topics: Anesthesia, General; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Pain; Propofol | 2023 |
Esketamine: A Novel Option for Treatment-Resistant Depression.
Topics: Administration, Intranasal; Administration, Oral; Adult; Antidepressive Agents; Blood Pressure; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ketamine; United States; United States Food and Drug Administration | 2020 |
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.
Topics: Administration, Intranasal; Administration, Intravenous; Antidepressive Agents; Anxiety; Disease Management; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Ketamine; Mood Disorders; Nausea | 2021 |
5 other study(ies) available for esketamine and Adverse Drug Event
| Article | Year |
|---|---|
Association of intranasal esketamine, a novel 'standard of care' treatment and outcomes in the management of patients with treatment-resistant depression: protocol of a prospective cohort observational study of naturalistic clinical practice.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Multicenter Studies as Topic; Observational Studies as Topic; Prospective Studies; Treatment Outcome | 2022 |
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.
Topics: Administration, Intranasal; Adult; Antidepressive Agents; Comorbidity; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Retrospective Studies; Substance-Related Disorders | 2023 |
Patient-reported side effects and satisfaction of pre-hospital analgesia with low-dose esketamine: a cross-sectional study.
Topics: Aged; Aged, 80 and over; Analgesia; Cross-Sectional Studies; Drug-Related Side Effects and Adverse Reactions; Female; Hospitals; Humans; Male; Middle Aged; Pain; Patient Reported Outcome Measures; Patient Satisfaction; Personal Satisfaction | 2023 |
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System.
Topics: Adverse Drug Reaction Reporting Systems; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Ketamine; Marketing; Pharmacovigilance; Prospective Studies | 2021 |
Comparative efficacy and side-effect profile of ketamine and esketamine in the treatment of unipolar and bipolar depression: protocol for a systematic review and network meta-analysis.
Topics: Bipolar Disorder; Drug-Related Side Effects and Adverse Reactions; Humans; Ketamine; Meta-Analysis as Topic; Network Meta-Analysis; Randomized Controlled Trials as Topic; Review Literature as Topic | 2021 |